118 related articles for article (PubMed ID: 7496336)
1. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
Esser P; Bresgen M; Fischbach R; Heimann K; Wiedemann P
Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
Kauffmann DJ; van Meurs JC; Mertens DA; Peperkamp E; Master C; Gerritsen ME
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
[TBL] [Abstract][Full Text] [Related]
3. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
5. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
Clausen R; Weller M; Hilgers RD; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):283-6. PubMed ID: 2376377
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
8. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
Adamiec-Mroczek J; Oficjalska-Młyńczak J; Misiuk-Hojło M
Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
10. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
[TBL] [Abstract][Full Text] [Related]
11. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
12. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in proliferative vitreoretinopathy.
Limb GA; Little BC; Meager A; Ogilvie JA; Wolstencroft RA; Franks WA; Chignell AH; Dumonde DC
Eye (Lond); 1991; 5 ( Pt 6)():686-93. PubMed ID: 1800167
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of integrins in proliferative retinal membranes.
Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
